Daesang expands allulose business and investors assess Daesang stock

Published on 10/20/2026 at 03:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Daesang grew North American allulose sales 450 percent in 2025 through Sweevero. Daesang stock awaits results on November 18, 2026.

Allulose growth and upcoming results

Daesang announced North American allulose sales growth of 450 percent for 2025 on October 16, 2026.
Second-quarter 2026 revenue reached KRW 1.17 trillion, up 8.30 percent year over year.
Daesang's next earnings report is scheduled for November 18, 2026.

Daesang, KR7001680008, Illustration mit AI erstellt.

Daesang Corporation (ISIN KR7001680008) is expanding its North American allulose business after reporting 450 percent year-over-year sales growth in 2025. The company said on October 16, 2026, that its Sweevero brand will support broader sugar-reduction solutions for food manufacturers, according to Yahoo Finance.

North America becomes the test

Daesang entered the North American allulose market in 2023 and launched Sweevero in 2024. The October 16 announcement says the company is moving beyond bulk sweetener supply toward customized blends and taste-modulation technology for beverages, dairy products, confectionery, nutrition products and sauces.

The expansion has an operating base in South Korea. Daesang invested KRW 30 billion in July 2023 to establish a dedicated allulose facility at its Gunsan starch and sweetener plant, the company said in the release carried by Yahoo Finance.

What does the latest quarter show?

Daesang reported KRW 1.17 trillion of revenue in the second quarter of 2026, an 8.30 percent increase from the same quarter a year earlier. Operating profit reached KRW 46.50 billion and net income KRW 19.60 billion, according to ATS View. The figures put the latest quarterly operating margin at 4.00 percent.

For investors, the comparison is important because first-quarter revenue stood at KRW 1.11 trillion while operating profit was KRW 57.00 billion. The second quarter therefore delivered higher revenue but lower operating profit, a mix that makes execution in the growing ingredient business relevant to the next results update.

Next date is November 18

Daesang's next earnings report is scheduled for November 18, 2026, according to Investing.com. The report should provide the next dated test of revenue growth, operating profit and the contribution from the company's international ingredient strategy.

Stock profile and valuation context

Daesang trades on the Korea Exchange KOSPI market under ticker 001680, and its 52-week range was KRW 15,880 to KRW 24,150 as of October 20, 2026. Its market capitalization was KRW 614.3 billion on that date. The company belongs to the consumer defensive sector and packaged foods industry.